Preload Image
Preload Image
Report Store mobile icon
Global COVID-19 Rapid Antibody Test Kits Market Outlook, 2030

Global COVID-19 Rapid Antibody Test Kits Market Outlook, 2030

2025

Global COVID-19 Rapid Antibody Test Kits Market Outlook, 2030

The global COVID-19 rapid antibody test kits market was valued at $42.45 billion in 2023, driven by the demand for quick and accessible COVID-19 testing.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global COVID-19 rapid antibody test kits market experienced significant growth during the pandemic. These kits detect antibodies produced by the body in response to the virus, indicating past infection or vaccination. The market growth was driven by the urgent need for widespread testing to understand the spread of the virus, identify individuals with immunity, and support public health measures. Several factors contributed to the market's expansion. The rapid spread of COVID-19 necessitated quick and accessible testing solutions, leading to the adoption of rapid antibody tests in various settings, including hospitals, clinics, and homes. Governments and healthcare organizations worldwide invested heavily in procuring and distributing these kits to manage the pandemic effectively. The convenience and ease of use of rapid antibody tests, with results available within minutes, made them a popular choice for mass testing initiatives. However, the market also faced challenges. Concerns about the accuracy and reliability of some rapid antibody tests emerged, leading to regulatory scrutiny and the need for stringent quality control measures. The emergence of new variants of the virus also raised questions about the effectiveness of existing antibody tests in detecting immunity against these variants. Despite these challenges, the global COVID-19 rapid antibody test kits market played a crucial role in the fight against the pandemic, providing valuable information about the prevalence of infection and immune response in populations.

According to our LPI (LP Information) latest study, the global COVID-19 Rapid Antibody Test Kits market size was valued at US$ 42450 million in 2023. With growing demand in downstream market, the COVID-19 Rapid Antibody Test Kits is forecast to a readjusted size of US$ 7121.4 million by 2030 with a CAGR of -22.5% during review period. The research report highlights the growth potential of the global COVID-19 Rapid Antibody Test Kits market. COVID-19 Rapid Antibody Test Kits are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of COVID-19 Rapid Antibody Test Kits. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the COVID-19 Rapid Antibody Test Kits market. In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets. The report on COVID-19 Rapid Antibody Test Kits market reflects various aspects and provide valuable insights into the industry. The research report provide an overview of the current size and growth of the COVID-19 Rapid Antibody Test Kits market. It may include historical data, market segmentation by Type (e.g., IgG Test, IgM Test), and regional breakdowns. The report can identify and analyse the factors driving the growth of the COVID-19 Rapid Antibody Test Kits market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The global COVID-19 rapid antibody test kits market experienced extraordinary growth during the pandemic, fueled by the pressing need for widespread serological testing to understand the virus's transmission dynamics and identify individuals who had developed immunity, whether through prior infection or vaccination. This surge in demand stemmed from the convenience and accessibility of these tests, which deliver results within minutes, making them ideal for mass testing initiatives across diverse settings, from homes and workplaces to clinics and hospitals. The market is broadly segmented by test type, primarily into laboratory-based rapid tests and over-the-counter (OTC) or home-use rapid tests. Laboratory-based tests, designed for professional use in healthcare facilities, typically involve a blood sample and are processed by trained personnel, often utilizing more sophisticated equipment. These tests may offer higher sensitivity and specificity, potentially detecting lower levels of antibodies or differentiating between different types of antibodies. Conversely, OTC or home-use rapid tests are designed for self-administration, empowering individuals to conduct testing in the comfort of their own homes. These tests usually involve a finger-prick blood sample or saliva and provide rapid results, typically within 10-15 minutes. The ease of use and rapid turnaround time of these home-use tests made them a popular choice for mass testing programs and individual monitoring. However, the convenience of home-use tests comes with potential trade-offs regarding accuracy compared to laboratory-based assays. Concerns about the sensitivity and specificity of some home-use tests, particularly in detecting low antibody levels or in individuals with mild or asymptomatic infections, have led to increased regulatory scrutiny and a focus on quality control measures. Furthermore, the emergence of new SARS-CoV-2 variants raised questions about the effectiveness of existing antibody tests in detecting antibodies against these variants and assessing cross-reactive immunity. Despite these challenges related to accuracy and the evolving nature of the virus, both laboratory-based and home-use rapid antibody tests played a crucial role in managing the pandemic. They provided valuable epidemiological data on infection prevalence, helped track the spread of the virus, and offered insights into the immune response at both individual and population levels, contributing significantly to public health efforts.

The global COVID-19 rapid antibody test kits market catered to a diverse range of applications during the pandemic, playing a crucial role in various aspects of disease management and public health strategies. One primary application was seroprevalence studies, where these kits were deployed to assess the proportion of a population that had developed antibodies against the virus, indicating past infection or vaccination. These studies provided valuable insights into the extent of virus spread, the effectiveness of public health interventions, and the overall immune status of communities. Another key application was in contact tracing, where rapid antibody tests helped identify individuals who might have been previously infected and thus potentially exposed others, aiding in efforts to break transmission chains. In vaccine development and evaluation, these kits were used to measure antibody responses in vaccine candidates and assess the efficacy of different vaccination strategies. They also played a role in personal health monitoring, allowing individuals to check their own antibody levels to gauge potential immunity or the need for booster shots. Furthermore, rapid antibody tests found application in research settings, contributing to a deeper understanding of the virus's behavior, the human immune response, and the long-term effects of infection. In some cases, they were also used in clinical diagnosis, particularly when RT-PCR tests were unavailable or delayed, to provide supplementary information about a patient's infection status. The diverse applications of rapid antibody test kits contributed significantly to the global efforts to combat the pandemic by providing critical information for public health decision-making, individual health management, and scientific advancements.
The global COVID-19 rapid antibody test kits market exhibited varying dynamics across different regions during the pandemic. North America, particularly the United States, held a significant market share due to a high prevalence of COVID-19 cases, a well-established healthcare infrastructure, and substantial government investments in testing and diagnostics. Europe also witnessed considerable market growth, driven by similar factors such as a high infection rate and robust healthcare systems. In Asia Pacific, the market expanded rapidly due to a large population base, increasing awareness about COVID-19, and government initiatives to promote widespread testing. The region's diverse healthcare systems and varying levels of pandemic preparedness led to a fragmented market landscape, with some countries experiencing higher adoption rates than others. Latin America and the Middle East & Africa also contributed to the market's growth, although their shares were relatively smaller compared to North America, Europe, and Asia Pacific. Factors such as limited healthcare resources, varying access to testing, and diverse public health strategies influenced the market dynamics in these regions. The regional analysis of the global COVID-19 rapid antibody test kits market reveals a complex interplay of factors, including pandemic prevalence, healthcare infrastructure, government policies, and public awareness, which shaped the market's growth and evolution across different parts of the world.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global COVID-19 Rapid Antigen Test Kits Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for COVID-19 Rapid Antigen Test Kits by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for COVID-19 Rapid Antigen Test Kits by Country/Region, 2019, 2023 & 2030
  • 2.2 COVID-19 Rapid Antigen Test Kits Segment by Type
  • 2.2.1 Fluorescence Immunochromatography
  • 2.2.2 Colloidal Gold Immunochromatography
  • 2.2.3 Latex Immunochromatography
  • 2.2.4 Others
  • 2.3 COVID-19 Rapid Antigen Test Kits Sales by Type
  • 2.3.1 Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Type (2019-2024)
  • 2.3.2 Global COVID-19 Rapid Antigen Test Kits Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global COVID-19 Rapid Antigen Test Kits Sale Price by Type (2019-2024)
  • 2.4 COVID-19 Rapid Antigen Test Kits Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Home
  • 2.4.3 School
  • 2.4.4 Third-Party Detection Institution
  • 2.4.5 Others
  • 2.5 COVID-19 Rapid Antigen Test Kits Sales by Application
  • 2.5.1 Global COVID-19 Rapid Antigen Test Kits Sale Market Share by Application (2019-2024)
  • 2.5.2 Global COVID-19 Rapid Antigen Test Kits Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global COVID-19 Rapid Antigen Test Kits Sale Price by Application (2019-2024)
  • 3 Global COVID-19 Rapid Antigen Test Kits by Company
  • 3.1 Global COVID-19 Rapid Antigen Test Kits Breakdown Data by Company
  • 3.1.1 Global COVID-19 Rapid Antigen Test Kits Annual Sales by Company (2019-2024)
  • 3.1.2 Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Company (2019-2024)
  • 3.2 Global COVID-19 Rapid Antigen Test Kits Annual Revenue by Company (2019-2024)
  • 3.2.1 Global COVID-19 Rapid Antigen Test Kits Revenue by Company (2019-2024)
  • 3.2.2 Global COVID-19 Rapid Antigen Test Kits Revenue Market Share by Company (2019-2024)
  • 3.3 Global COVID-19 Rapid Antigen Test Kits Sale Price by Company
  • 3.4 Key Manufacturers COVID-19 Rapid Antigen Test Kits Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers COVID-19 Rapid Antigen Test Kits Product Location Distribution
  • 3.4.2 Players COVID-19 Rapid Antigen Test Kits Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for COVID-19 Rapid Antigen Test Kits by Geographic Region
  • 4.1 World Historic COVID-19 Rapid Antigen Test Kits Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global COVID-19 Rapid Antigen Test Kits Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global COVID-19 Rapid Antigen Test Kits Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic COVID-19 Rapid Antigen Test Kits Market Size by Country/Region (2019-2024)
  • 4.2.1 Global COVID-19 Rapid Antigen Test Kits Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global COVID-19 Rapid Antigen Test Kits Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas COVID-19 Rapid Antigen Test Kits Sales Growth
  • 4.4 APAC COVID-19 Rapid Antigen Test Kits Sales Growth
  • 4.5 Europe COVID-19 Rapid Antigen Test Kits Sales Growth
  • 4.6 Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales Growth
  • 5 Americas
  • 5.1 Americas COVID-19 Rapid Antigen Test Kits Sales by Country
  • 5.1.1 Americas COVID-19 Rapid Antigen Test Kits Sales by Country (2019-2024)
  • 5.1.2 Americas COVID-19 Rapid Antigen Test Kits Revenue by Country (2019-2024)
  • 5.2 Americas COVID-19 Rapid Antigen Test Kits Sales by Type
  • 5.3 Americas COVID-19 Rapid Antigen Test Kits Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC COVID-19 Rapid Antigen Test Kits Sales by Region
  • 6.1.1 APAC COVID-19 Rapid Antigen Test Kits Sales by Region (2019-2024)
  • 6.1.2 APAC COVID-19 Rapid Antigen Test Kits Revenue by Region (2019-2024)
  • 6.2 APAC COVID-19 Rapid Antigen Test Kits Sales by Type
  • 6.3 APAC COVID-19 Rapid Antigen Test Kits Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe COVID-19 Rapid Antigen Test Kits by Country
  • 7.1.1 Europe COVID-19 Rapid Antigen Test Kits Sales by Country (2019-2024)
  • 7.1.2 Europe COVID-19 Rapid Antigen Test Kits Revenue by Country (2019-2024)
  • 7.2 Europe COVID-19 Rapid Antigen Test Kits Sales by Type
  • 7.3 Europe COVID-19 Rapid Antigen Test Kits Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa COVID-19 Rapid Antigen Test Kits by Country
  • 8.1.1 Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales by Type
  • 8.3 Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of COVID-19 Rapid Antigen Test Kits
  • 10.3 Manufacturing Process Analysis of COVID-19 Rapid Antigen Test Kits
  • 10.4 Industry Chain Structure of COVID-19 Rapid Antigen Test Kits
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 COVID-19 Rapid Antigen Test Kits Distributors
  • 11.3 COVID-19 Rapid Antigen Test Kits Customer
  • 12 World Forecast Review for COVID-19 Rapid Antigen Test Kits by Geographic Region
  • 12.1 Global COVID-19 Rapid Antigen Test Kits Market Size Forecast by Region
  • 12.1.1 Global COVID-19 Rapid Antigen Test Kits Forecast by Region (2025-2030)
  • 12.1.2 Global COVID-19 Rapid Antigen Test Kits Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global COVID-19 Rapid Antigen Test Kits Forecast by Type
  • 12.7 Global COVID-19 Rapid Antigen Test Kits Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Abbott
  • 13.1.1 Abbott Company Information
  • 13.1.2 Abbott COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.1.3 Abbott COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Abbott Main Business Overview
  • 13.1.5 Abbott Latest Developments
  • 13.2 Quidel
  • 13.2.1 Quidel Company Information
  • 13.2.2 Quidel COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.2.3 Quidel COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Quidel Main Business Overview
  • 13.2.5 Quidel Latest Developments
  • 13.3 ACCESS BIO
  • 13.3.1 ACCESS BIO Company Information
  • 13.3.2 ACCESS BIO COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.3.3 ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 ACCESS BIO Main Business Overview
  • 13.3.5 ACCESS BIO Latest Developments
  • 13.4 CTK Biotech
  • 13.4.1 CTK Biotech Company Information
  • 13.4.2 CTK Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.4.3 CTK Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 CTK Biotech Main Business Overview
  • 13.4.5 CTK Biotech Latest Developments
  • 13.5 SD Biosensor
  • 13.5.1 SD Biosensor Company Information
  • 13.5.2 SD Biosensor COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.5.3 SD Biosensor COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 SD Biosensor Main Business Overview
  • 13.5.5 SD Biosensor Latest Developments
  • 13.6 Ellume
  • 13.6.1 Ellume Company Information
  • 13.6.2 Ellume COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.6.3 Ellume COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 Ellume Main Business Overview
  • 13.6.5 Ellume Latest Developments
  • 13.7 InBios
  • 13.7.1 InBios Company Information
  • 13.7.2 InBios COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.7.3 InBios COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 InBios Main Business Overview
  • 13.7.5 InBios Latest Developments
  • 13.8 Celltrion
  • 13.8.1 Celltrion Company Information
  • 13.8.2 Celltrion COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.8.3 Celltrion COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Celltrion Main Business Overview
  • 13.8.5 Celltrion Latest Developments
  • 13.9 AESKU.GROUP
  • 13.9.1 AESKU.GROUP Company Information
  • 13.9.2 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.9.3 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 AESKU.GROUP Main Business Overview
  • 13.9.5 AESKU.GROUP Latest Developments
  • 13.10 ROCHE
  • 13.10.1 ROCHE Company Information
  • 13.10.2 ROCHE COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.10.3 ROCHE COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 ROCHE Main Business Overview
  • 13.10.5 ROCHE Latest Developments
  • 13.11 BD
  • 13.11.1 BD Company Information
  • 13.11.2 BD COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.11.3 BD COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 BD Main Business Overview
  • 13.11.5 BD Latest Developments
  • 13.12 OraSure Technologies
  • 13.12.1 OraSure Technologies Company Information
  • 13.12.2 OraSure Technologies COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.12.3 OraSure Technologies COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.12.4 OraSure Technologies Main Business Overview
  • 13.12.5 OraSure Technologies Latest Developments
  • 13.13 Clip Health
  • 13.13.1 Clip Health Company Information
  • 13.13.2 Clip Health COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.13.3 Clip Health COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.13.4 Clip Health Main Business Overview
  • 13.13.5 Clip Health Latest Developments
  • 13.14 LumiraDx
  • 13.14.1 LumiraDx Company Information
  • 13.14.2 LumiraDx COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.14.3 LumiraDx COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.14.4 LumiraDx Main Business Overview
  • 13.14.5 LumiraDx Latest Developments
  • 13.15 Princeton BioMeditech Corporation
  • 13.15.1 Princeton BioMeditech Corporation Company Information
  • 13.15.2 Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.15.3 Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.15.4 Princeton BioMeditech Corporation Main Business Overview
  • 13.15.5 Princeton BioMeditech Corporation Latest Developments
  • 13.16 RapiGEN Inc.
  • 13.16.1 RapiGEN Inc. Company Information
  • 13.16.2 RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.16.3 RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.16.4 RapiGEN Inc. Main Business Overview
  • 13.16.5 RapiGEN Inc. Latest Developments
  • 13.17 Orient Gene
  • 13.17.1 Orient Gene Company Information
  • 13.17.2 Orient Gene COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.17.3 Orient Gene COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.17.4 Orient Gene Main Business Overview
  • 13.17.5 Orient Gene Latest Developments
  • 13.18 Wondfo Biotech
  • 13.18.1 Wondfo Biotech Company Information
  • 13.18.2 Wondfo Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.18.3 Wondfo Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.18.4 Wondfo Biotech Main Business Overview
  • 13.18.5 Wondfo Biotech Latest Developments
  • 13.19 Ihealth (Andon Health)
  • 13.19.1 Ihealth (Andon Health) Company Information
  • 13.19.2 Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.19.3 Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.19.4 Ihealth (Andon Health) Main Business Overview
  • 13.19.5 Ihealth (Andon Health) Latest Developments
  • 13.20 Wantai BioPharm
  • 13.20.1 Wantai BioPharm Company Information
  • 13.20.2 Wantai BioPharm COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.20.3 Wantai BioPharm COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.20.4 Wantai BioPharm Main Business Overview
  • 13.20.5 Wantai BioPharm Latest Developments
  • 13.21 Biotest Biotech
  • 13.21.1 Biotest Biotech Company Information
  • 13.21.2 Biotest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.21.3 Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.21.4 Biotest Biotech Main Business Overview
  • 13.21.5 Biotest Biotech Latest Developments
  • 13.22 Shenzhen YHLO Biotech
  • 13.22.1 Shenzhen YHLO Biotech Company Information
  • 13.22.2 Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.22.3 Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.22.4 Shenzhen YHLO Biotech Main Business Overview
  • 13.22.5 Shenzhen YHLO Biotech Latest Developments
  • 13.23 Vazyme Biotech
  • 13.23.1 Vazyme Biotech Company Information
  • 13.23.2 Vazyme Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.23.3 Vazyme Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.23.4 Vazyme Biotech Main Business Overview
  • 13.23.5 Vazyme Biotech Latest Developments
  • 13.24 EasyDiagnosis Biomedicine
  • 13.24.1 EasyDiagnosis Biomedicine Company Information
  • 13.24.2 EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.24.3 EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.24.4 EasyDiagnosis Biomedicine Main Business Overview
  • 13.24.5 EasyDiagnosis Biomedicine Latest Developments
  • 13.25 Beijing Hotgen Biotech
  • 13.25.1 Beijing Hotgen Biotech Company Information
  • 13.25.2 Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.25.3 Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.25.4 Beijing Hotgen Biotech Main Business Overview
  • 13.25.5 Beijing Hotgen Biotech Latest Developments
  • 13.26 Assure Tech
  • 13.26.1 Assure Tech Company Information
  • 13.26.2 Assure Tech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.26.3 Assure Tech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.26.4 Assure Tech Main Business Overview
  • 13.26.5 Assure Tech Latest Developments
  • 13.27 Hangzhou AllTest Biotech
  • 13.27.1 Hangzhou AllTest Biotech Company Information
  • 13.27.2 Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.27.3 Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.27.4 Hangzhou AllTest Biotech Main Business Overview
  • 13.27.5 Hangzhou AllTest Biotech Latest Developments
  • 13.28 ACON Biotech
  • 13.28.1 ACON Biotech Company Information
  • 13.28.2 ACON Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.28.3 ACON Biotech COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.28.4 ACON Biotech Main Business Overview
  • 13.28.5 ACON Biotech Latest Developments
  • 13.29 BGI Genomics
  • 13.29.1 BGI Genomics Company Information
  • 13.29.2 BGI Genomics COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.29.3 BGI Genomics COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.29.4 BGI Genomics Main Business Overview
  • 13.29.5 BGI Genomics Latest Developments
  • 13.30 Lepu Medical Technology
  • 13.30.1 Lepu Medical Technology Company Information
  • 13.30.2 Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
  • 13.30.3 Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.30.4 Lepu Medical Technology Main Business Overview
  • 13.30.5 Lepu Medical Technology Latest Developments
  • 13.31 Jinwofu Bioengineering Technology
  • 13.32 Phase Scientific
  • 14 Research Findings and Conclusion

List of Tables
Table 1. COVID-19 Rapid Antigen Test Kits Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. COVID-19 Rapid Antigen Test Kits Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Fluorescence Immunochromatography
Table 4. Major Players of Colloidal Gold Immunochromatography
Table 5. Major Players of Latex Immunochromatography
Table 6. Major Players of Others
Table 7. Global COVID-19 Rapid Antigen Test Kits Sales by Type (2019-2024) & (M Units)
Table 8. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Type (2019-2024)
Table 9. Global COVID-19 Rapid Antigen Test Kits Revenue by Type (2019-2024) & ($ million)
Table 10. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share by Type (2019-2024)
Table 11. Global COVID-19 Rapid Antigen Test Kits Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global COVID-19 Rapid Antigen Test Kits Sales by Application (2019-2024) & (M Units)
Table 13. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Application (2019-2024)
Table 14. Global COVID-19 Rapid Antigen Test Kits Revenue by Application (2019-2024)
Table 15. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share by Application (2019-2024)
Table 16. Global COVID-19 Rapid Antigen Test Kits Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global COVID-19 Rapid Antigen Test Kits Sales by Company (2019-2024) & (M Units)
Table 18. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Company (2019-2024)
Table 19. Global COVID-19 Rapid Antigen Test Kits Revenue by Company (2019-2024) ($ Millions)
Table 20. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share by Company (2019-2024)
Table 21. Global COVID-19 Rapid Antigen Test Kits Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers COVID-19 Rapid Antigen Test Kits Producing Area Distribution and Sales Area
Table 23. Players COVID-19 Rapid Antigen Test Kits Products Offered
Table 24. COVID-19 Rapid Antigen Test Kits Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global COVID-19 Rapid Antigen Test Kits Sales by Geographic Region (2019-2024) & (M Units)
Table 28. Global COVID-19 Rapid Antigen Test Kits Sales Market Share Geographic Region (2019-2024)
Table 29. Global COVID-19 Rapid Antigen Test Kits Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global COVID-19 Rapid Antigen Test Kits Sales by Country/Region (2019-2024) & (M Units)
Table 32. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Country/Region (2019-2024)
Table 33. Global COVID-19 Rapid Antigen Test Kits Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas COVID-19 Rapid Antigen Test Kits Sales by Country (2019-2024) & (M Units)
Table 36. Americas COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2019-2024)
Table 37. Americas COVID-19 Rapid Antigen Test Kits Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country (2019-2024)
Table 39. Americas COVID-19 Rapid Antigen Test Kits Sales by Type (2019-2024) & (M Units)
Table 40. Americas COVID-19 Rapid Antigen Test Kits Sales by Application (2019-2024) & (M Units)
Table 41. APAC COVID-19 Rapid Antigen Test Kits Sales by Region (2019-2024) & (M Units)
Table 42. APAC COVID-19 Rapid Antigen Test Kits Sales Market Share by Region (2019-2024)
Table 43. APAC COVID-19 Rapid Antigen Test Kits Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC COVID-19 Rapid Antigen Test Kits Revenue Market Share by Region (2019-2024)
Table 45. APAC COVID-19 Rapid Antigen Test Kits Sales by Type (2019-2024) & (M Units)
Table 46. APAC COVID-19 Rapid Antigen Test Kits Sales by Application (2019-2024) & (M Units)
Table 47. Europe COVID-19 Rapid Antigen Test Kits Sales by Country (2019-2024) & (M Units)
Table 48. Europe COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2019-2024)
Table 49. Europe COVID-19 Rapid Antigen Test Kits Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country (2019-2024)
Table 51. Europe COVID-19 Rapid Antigen Test Kits Sales by Type (2019-2024) & (M Units)
Table 52. Europe COVID-19 Rapid Antigen Test Kits Sales by Application (2019-2024) & (M Units)
Table 53. Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales by Country (2019-2024) & (M Units)
Table 54. Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales by Type (2019-2024) & (M Units)
Table 58. Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales by Application (2019-2024) & (M Units)
Table 59. Key Market Drivers & Growth Opportunities of COVID-19 Rapid Antigen Test Kits
Table 60. Key Market Challenges & Risks of COVID-19 Rapid Antigen Test Kits
Table 61. Key Industry Trends of COVID-19 Rapid Antigen Test Kits
Table 62. COVID-19 Rapid Antigen Test Kits Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. COVID-19 Rapid Antigen Test Kits Distributors List
Table 65. COVID-19 Rapid Antigen Test Kits Customer List
Table 66. Global COVID-19 Rapid Antigen Test Kits Sales Forecast by Region (2025-2030) & (M Units)
Table 67. Global COVID-19 Rapid Antigen Test Kits Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas COVID-19 Rapid Antigen Test Kits Sales Forecast by Country (2025-2030) & (M Units)
Table 69. Americas COVID-19 Rapid Antigen Test Kits Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC COVID-19 Rapid Antigen Test Kits Sales Forecast by Region (2025-2030) & (M Units)
Table 71. APAC COVID-19 Rapid Antigen Test Kits Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe COVID-19 Rapid Antigen Test Kits Sales Forecast by Country (2025-2030) & (M Units)
Table 73. Europe COVID-19 Rapid Antigen Test Kits Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales Forecast by Country (2025-2030) & (M Units)
Table 75. Middle East & Africa COVID-19 Rapid Antigen Test Kits Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global COVID-19 Rapid Antigen Test Kits Sales Forecast by Type (2025-2030) & (M Units)
Table 77. Global COVID-19 Rapid Antigen Test Kits Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global COVID-19 Rapid Antigen Test Kits Sales Forecast by Application (2025-2030) & (M Units)
Table 79. Global COVID-19 Rapid Antigen Test Kits Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Abbott Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 81. Abbott COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 82. Abbott COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Abbott Main Business
Table 84. Abbott Latest Developments
Table 85. Quidel Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 86. Quidel COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 87. Quidel COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Quidel Main Business
Table 89. Quidel Latest Developments
Table 90. ACCESS BIO Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 91. ACCESS BIO COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 92. ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. ACCESS BIO Main Business
Table 94. ACCESS BIO Latest Developments
Table 95. CTK Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 96. CTK Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 97. CTK Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. CTK Biotech Main Business
Table 99. CTK Biotech Latest Developments
Table 100. SD Biosensor Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 101. SD Biosensor COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 102. SD Biosensor COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. SD Biosensor Main Business
Table 104. SD Biosensor Latest Developments
Table 105. Ellume Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 106. Ellume COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 107. Ellume COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Ellume Main Business
Table 109. Ellume Latest Developments
Table 110. InBios Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 111. InBios COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 112. InBios COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. InBios Main Business
Table 114. InBios Latest Developments
Table 115. Celltrion Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 116. Celltrion COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 117. Celltrion COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Celltrion Main Business
Table 119. Celltrion Latest Developments
Table 120. AESKU.GROUP Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 121. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 122. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. AESKU.GROUP Main Business
Table 124. AESKU.GROUP Latest Developments
Table 125. ROCHE Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 126. ROCHE COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 127. ROCHE COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. ROCHE Main Business
Table 129. ROCHE Latest Developments
Table 130. BD Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 131. BD COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 132. BD COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. BD Main Business
Table 134. BD Latest Developments
Table 135. OraSure Technologies Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 136. OraSure Technologies COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 137. OraSure Technologies COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. OraSure Technologies Main Business
Table 139. OraSure Technologies Latest Developments
Table 140. Clip Health Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 141. Clip Health COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 142. Clip Health COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Clip Health Main Business
Table 144. Clip Health Latest Developments
Table 145. LumiraDx Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 146. LumiraDx COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 147. LumiraDx COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. LumiraDx Main Business
Table 149. LumiraDx Latest Developments
Table 150. Princeton BioMeditech Corporation Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 151. Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 152. Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Princeton BioMeditech Corporation Main Business
Table 154. Princeton BioMeditech Corporation Latest Developments
Table 155. RapiGEN Inc. Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 156. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 157. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. RapiGEN Inc. Main Business
Table 159. RapiGEN Inc. Latest Developments
Table 160. Orient Gene Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 161. Orient Gene COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 162. Orient Gene COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Orient Gene Main Business
Table 164. Orient Gene Latest Developments
Table 165. Wondfo Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 166. Wondfo Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 167. Wondfo Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Wondfo Biotech Main Business
Table 169. Wondfo Biotech Latest Developments
Table 170. Ihealth (Andon Health) Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 171. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 172. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Ihealth (Andon Health) Main Business
Table 174. Ihealth (Andon Health) Latest Developments
Table 175. Wantai BioPharm Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 176. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 177. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Wantai BioPharm Main Business
Table 179. Wantai BioPharm Latest Developments
Table 180. Biotest Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 181. Biotest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 182. Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. Biotest Biotech Main Business
Table 184. Biotest Biotech Latest Developments
Table 185. Shenzhen YHLO Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 186. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 187. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Shenzhen YHLO Biotech Main Business
Table 189. Shenzhen YHLO Biotech Latest Developments
Table 190. Vazyme Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 191. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 192. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 193. Vazyme Biotech Main Business
Table 194. Vazyme Biotech Latest Developments
Table 195. EasyDiagnosis Biomedicine Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 196. EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 197. EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 198. EasyDiagnosis Biomedicine Main Business
Table 199. EasyDiagnosis Biomedicine Latest Developments
Table 200. Beijing Hotgen Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 201. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 202. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 203. Beijing Hotgen Biotech Main Business
Table 204. Beijing Hotgen Biotech Latest Developments
Table 205. Assure Tech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 206. Assure Tech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 207. Assure Tech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 208. Assure Tech Main Business
Table 209. Assure Tech Latest Developments
Table 210. Hangzhou AllTest Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 211. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 212. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 213. Hangzhou AllTest Biotech Main Business
Table 214. Hangzhou AllTest Biotech Latest Developments
Table 215. ACON Biotech Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 216. ACON Biotech COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 217. ACON Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 218. ACON Biotech Main Business
Table 219. ACON Biotech Latest Developments
Table 220. BGI Genomics Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 221. BGI Genomics COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 222. BGI Genomics COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 223. BGI Genomics Main Business
Table 224. BGI Genomics Latest Developments
Table 225. Lepu Medical Technology Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 226. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 227. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 228. Lepu Medical Technology Main Business
Table 229. Lepu Medical Technology Latest Developments
Table 230. Jinwofu Bioengineering Technology Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 231. Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 232. Jinwofu Bioengineering Technology COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 233. Jinwofu Bioengineering Technology Main Business
Table 234. Jinwofu Bioengineering Technology Latest Developments
Table 235. Phase Scientific Basic Information, COVID-19 Rapid Antigen Test Kits Manufacturing Base, Sales Area and Its Competitors
Table 236. Phase Scientific COVID-19 Rapid Antigen Test Kits Product Portfolios and Specifications
Table 237. Phase Scientific COVID-19 Rapid Antigen Test Kits Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 238. Phase Scientific Main Business
Table 239. Phase Scientific Latest Developments

0

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global COVID-19 Rapid Antibody Test Kits Market Outlook, 2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.